Cilo Cybin Holdings Ltd

CCC · JSE · Healthcare / Drug Manufacturers - Specialty & Generic

90.00ZAC+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close90.00

Open90.00

Day Range90.00 – 90.00

52-Week Range70.00 – 690.00

Volume1.00K

Market Cap429.25M

P/E (TTM)0.00

Forward P/E0.00

EPS-0.96

Dividend Yield0.00%

Beta0.58

50-Day Avg85.84

200-Day Avg38.14

About

Cilo Cybin Holdings Limited cultivates, manufactures, and sells medical cannabis products worldwide. The company offers CBD, THC, and THCV distillates; THC and CBD crude; CBD, CBG, and CBN isolates; CBD Nano Oil; oil in bottles, cannabis flower, and cannabis vapes; and topicals, capsules, and device products. It also provides flower sourcing, formulation, manufacturing, and primary and secondary packaging services. In addition, the company operates an online shop for its products under the Brand Shop name. Cilo Cybin Holdings Limited was founded in 2018 and is based in Centurion, South Africa.

Company Details

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
CEOMr. Gabriel Christiaan Theron
HeadquartersThe Point Office Park, Centurion, South Africa, 0157, South Africa
Websitehttps://www.cilocybin.com

Leadership

Mr. Gabriel Christiaan TheronFounder, CEO & Executive Director · b. 1981
Ms. Jessica Moodley-TheronActing CFO & Financial Director and Executive Director · b. 1982
Ms. Rouxne StygerCompany Secretary
Ms. Sascha Ramirez-VictorCompany Secretary

Financials

Income Statement

Currency: ZAR	2023-03-31	2024-03-31	2025-03-31	2026-03-31
Total Revenue	0	0	35.42M	28.81M
Growth (%)	-	-	-	-18.65%
Cost of Revenue	0	0	358.93K	19.83M
Gross Profit	0	0	-358.93K	8.99M
Gross Margin	-	-	-1.01%	31.19%
Operating Expense	538.00K	563.00K	4.74M	30.04M
Operating Income	-538.00K	-563.00K	-5.10M	-21.05M
Operating Margin	-	-	-14.39%	-73.04%
EBITDA	-540.00K	501.31K	90.13K	-235.45M
EBITDA Margin	-	-	0.25%	-817.13%
Net Income	-552.00K	455.44K	-585.72K	-239.73M
Net Income Margin	-	-	-1.65%	-831.99%
Interest Expense	14.09K	45.88K	316.91K	784.99K
Interest Expense % of Total Revenue	-	-	0.89%	2.72%

Balance Sheet

Currency: ZAR	2022-03-31	2023-03-31	2024-03-31	2025-03-31	2026-03-31
Total Assets	10.00K	77.24K	63.28M	62.77M	85.36M
Total Liabilities	0	619.24K	11.20M	5.43M	22.73M
Total Equity	10.00K	-542.00K	52.08M	57.34M	62.63M
Cash	10.00K	77.24K	-	58.31M	48.15M
Total Debt	-	302.00K	-	3.94M	5.02M
Net Debt	-10.00K	224.76K	516.04K	-54.37M	-43.13M

Cash Flow

Currency: ZAR	2022-03-31	2023-03-31	2024-03-31	2025-03-31	2026-03-31
Operating Cash Flow	0	-222.76K	632.28K	-2.08M	3.75M
Investing Cash Flow	-	-	-	-50.89K	44.95M
Financing Cash Flow	10.00K	290.00K	62.57M	-2.83M	-1.82M
Capital Expenditure	0	0	3	50.89K	9.37M
Free Cash Flow	0	-222.76K	632.28K	-2.13M	-5.62M
FCF to OCF	-	100.00%	100.00%	102.44%	-149.88%

Key Statistics & Ratios

Market Cap429.25M

Enterprise Value475.43M

Trailing P/E0.00

Forward P/E0.00

Price / Sales60.19

Price / Book8.28

EPS-0.96

Book Value0.348

Revenue (TTM)7.13M

Gross Profit (TTM)365.98K

EBITDA-222.89M

Profit Margin0.00%

Operating Margin-1159.17%

Return on Equity-273.22%

Return on Assets-164.45%

Shares Outstanding230.48M

Shares Float169.40M

Beta0.58

Dividend Yield0.00%

Dividend Rate0.00

Payout Ratio0.00%